COMPANY
Oorja Bio
Timeline
- Trial start Phase 2: Study of ORJ-001 for the Treatment of IPF source ↗
Upcoming milestones
- 2029-01 (ESTIMATED) · Phase 2 · Study of ORJ-001 for the Treatment of IPF · NCT07869147
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07869147 | Study of ORJ-001 for the Treatment of IPF | Phase 2 | Recruiting | 2026-10 | 2029-01 (estimated) |